Pacific Biosciences of California

PacBio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. We provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. Our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. With a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.

Menlo Park, US
Size (employees)
438 (est)+12%
Pacific Biosciences of California was founded in 2004 and is headquartered in Menlo Park, US

Pacific Biosciences of California Office Locations

Pacific Biosciences of California has an office in Menlo Park
Menlo Park, US (HQ)
1380 Willow Rd

Pacific Biosciences of California Metrics

Pacific Biosciences of California Financial Metrics

Revenue (2016)

$90.7 m

Revenue growth (2015-16), %


Gross profit

$44.2 m

Gross profit margin (2016), %


Net income (2016)

($74.4 m)

Market capitalization (21-Mar-2017)

$435.3 m

Closing share price (21-Mar-2017)


Cash (31-Dec-2016)

$16.8 m
Pacific Biosciences of California's current market capitalization is $435.3 m.
Pacific Biosciences of California's revenue was reported to be $90.7 m in FY, 2016 which is a 2.2% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$28.2 m$60.6 m$92.8 m$90.7 m

Revenue growth, %


Cost of goods sold

$21.8 m$37.2 m$39.3 m$46.6 m

Gross profit

$6.4 m$23.4 m$53.5 m$44.2 m

Gross profit Margin, %


Operating expense total

$84 m$86.3 m$82.6 m$115.4 m


($77.5 m)($62.9 m)($29.1 m)($71.2 m)

EBIT margin, %


Interest expense

$2.5 m$2.8 m$2.9 m$3.2 m

Net Income

($79.3 m)($66.2 m)($31.7 m)($74.4 m)
Y, 2009Y, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016


$89.2 m$147.7 m$58.9 m$46.5 m$26.4 m$36.4 m$33.6 m$16.8 m

Accounts Receivable

$2.7 m$3.4 m$5.2 m$11.4 m


$1.1 m$1.7 m$12.1 m$10 m

Current Assets

$126.5 m$117.8 m$110.5 m$109 m


$9.2 m$6.6 m$8.5 m$14.6 m

Total Assets

$136.2 m$124.5 m$131.1 m$137.9 m

Accounts Payable

$1.7 m$5.6 m$4.7 m$8.4 m

Total Debt

$2.6 m$28.2 m$29.9 m$32.2 m

Current Liabilities

$22.6 m$31.5 m$38.2 m$33.8 m

Additional Paid-in Capital

$684.4 m$736.3 m$786.6 m$872.1 m

Retained Earnings

($615.3 m)($681.5 m)($713.2 m)($787.5 m)

Total Equity

$69.2 m$54.9 m$73.5 m$84.7 m

Debt to Equity Ratio

0.5 x0.4 x0.4 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x

Financial Leverage

2 x2.3 x1.8 x1.6 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($79.3 m)($66.2 m)($31.7 m)($74.4 m)

Depreciation and Amortization

$5.6 m$4.2 m$3.7 m$3.9 m

Accounts Receivable

$76 k($660 k)($1.7 m)($6.2 m)


($60 k)($1.3 m)($2.5 m)($6.2 m)

Accounts Payable

($1.3 m)$3.9 m($716 k)$3.4 m

Cash From Operating Activities

($29.8 m)($51.5 m)($47.9 m)($67.9 m)

Purchases of PP&E

($909 k)($1.6 m)($3 m)($8.2 m)

Cash From Investing Activities

($33.1 m)$19.6 m$8.6 m($14.9 m)

Cash From Financing Activities

$42.8 m$42 m$36.5 m$65.9 m

Interest Paid

$1.2 m$1.8 m$1.8 m$1.8 m

Pacific Biosciences of California Market Value History

Pacific Biosciences of California Median Salaries

Source: 25 public H-1B filings from Pacific Biosciences of California

Pacific Biosciences of California Online Presence

Pacific Biosciences of California Company Life

You may also be interested in